Literature DB >> 27593195

A clinical audit cycle of post-operative hypothermia in dogs.

N Rose1, G P S Kwong2, D S J Pang3,4.   

Abstract

OBJECTIVES: Use of clinical audits to assess and improve perioperative hypothermia management in client-owned dogs.
METHODS: Two clinical audits were performed. In Audit 1 data were collected to determine the incidence and duration of perioperative hypothermia (defined as rectal temperatures <37·0°C). The results from Audit 1 were used to reach consensus on changes to be implemented to improve temperature management, including re-defining hypothermia as rectal temperature <37·5°C. Audit 2 was performed after 1 month with changes in place.
RESULTS: Audit 1 revealed a high incidence of post-operative hypothermia (88·0%) and prolonged time periods (7·5 hours) to reach normothermia. Consensus changes were to use a forced air warmer on all dogs and measure rectal temperatures hourly post-operatively until temperature ≥37·5°C. After 1 month with the implemented changes, Audit 2 identified a significant reduction in the time to achieve a rectal temperature of ≥37·5°C, with 75% of dogs achieving this goal by 3·5 hours. The incidence of hypothermia at tracheal extubation remained high in Audit 2 (97·3% with a rectal temperature <37·5°C). CLINICAL SIGNIFICANCE: Post-operative hypothermia was improved through simple changes in practice, showing that clinical audit is a useful tool for monitoring post-operative hypothermia and improving patient care. Overall management of perioperative hypothermia could be further improved with earlier intervention.
© 2016 British Small Animal Veterinary Association.

Entities:  

Mesh:

Year:  2016        PMID: 27593195     DOI: 10.1111/jsap.12547

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  9 in total

Review 1.  A practical guide to implementing clinical audit.

Authors:  Nicole Rose; Daniel S J Pang
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

2.  Effect of intravenous fluid warming on core body temperature during elective orthopedic procedures.

Authors:  Robert B E Brady; William T Poppell
Journal:  Can Vet J       Date:  2020-10       Impact factor: 1.008

3.  Heating Pad Performance and Efficacy of 2 Durations of Warming after Isoflurane Anesthesia of Sprague-Dawley Rats (Rattus norvegicus).

Authors:  Emily Q Zhang; Cameron G Knight; Daniel Sj Pang
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-11-01       Impact factor: 1.232

4.  Hypothermia During General Anesthesia Interferes with Pain Assessment in Laboratory Rats (Rattus norvegicus).

Authors:  Cassandra B Klune; Hayley Nk Robbins; Vivian Sy Leung; Daniel Sj Pang
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-09-09       Impact factor: 1.232

5.  Pre-warming following premedication limits hypothermia before and during anesthesia in Sprague-Dawley rats (Rattus norvegicus).

Authors:  Maxime Rufiange; Vivian S Y Leung; Keith Simpson; Daniel S J Pang
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

6.  Prewarming Followed by Active Warming is Superior to Passive Warming in Preventing Hypothermia for Short Procedures in Adult Rats (Rattus norvegicus) Under Isoflurane Anesthesia.

Authors:  Maxime Rufiange; Vivian Sy Leung; Keith Simpson; Daniel Sj Pang
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-08       Impact factor: 1.232

Review 7.  Morbidity and Mortality Conferences: A Mini Review and Illustrated Application in Veterinary Medicine.

Authors:  Daniel S J Pang; Frédérik Rousseau-Blass; Jessica M Pang
Journal:  Front Vet Sci       Date:  2018-03-06

8.  Pre-warming before general anesthesia with isoflurane delays the onset of hypothermia in rats.

Authors:  Maxime Rufiange; Vivian S Y Leung; Keith Simpson; Daniel S J Pang
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

Review 9.  Mouse Anesthesia: The Art and Science.

Authors:  Kaela L Navarro; Monika Huss; Jennifer C Smith; Patrick Sharp; James O Marx; Cholawat Pacharinsak
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.